Saturday 17 October 2026
Export ZYME’s income statement to Excel — free account
Zymeworks Inc.
ZYME Healthcare Biotechnology
Zymeworks Inc.’s revenue for fiscal 2025 (year ended December 2025) was $106.0 million, up 38.9% from fiscal 2024. In the quarter to June 2026, revenue fell 90.6%, EPS fell 2,166.7% and free cash flow fell 385.5%, each against the same quarter a year earlier.
25.07
0.68
−2.64%
Follow ZYME
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 4 | 3 |
| (18.46%) | (26.72%) | (42.02%) | (72.31%) | ||
| (14.34%) | (20.04%) | (22.72%) | (37.25%) | ||
ROIC |
(64.78%) | (144.67%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(23.89%) | (36.55%) | (28.13%) | (56.58%) | |
Average Days of Receivables |
79.67 | 15.98 | 20.99 | 58.30 | |
Free Cash Flow per Share |
(0.87) | (0.47) | (1.03) | (1.65) | |
Free Cash Flow |
(66.20) | (35.36) | (77.04) | (120.54) | |
Capital Expenditures |
(1.95) | (2.35) | (1.72) | (1.21) | |
| Other line items | |||||
Cash ROIC |
(11.57%) | (7.11%) | (14.57%) | (34.34%) | |
Accounts Receivable Turnover |
5.07 | 3.51 | 5.55 | 8.67 | |
Accounts Payable Turnover |
3.32 | 2.85 | 3.97 | 4.40 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
87.99 | 96.83 | 81.29 | 77.87 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.13 | 0.02 | (0.01) | (0.01) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.30% | 58.05% | 73.34% | 172.33% | |
Share Based Compensation of Revenue |
18.00% | 26.46% | 35.15% | 91.66% | |
Interest Coverage |
— | — | (6.83) | (8.41) | |
Operating CF/Net income |
1.01 | 0.41 | 0.73 | 0.80 | |
Depreciation/Fixed assets |
0.81 | 0.72 | 0.72 | 0.68 | |
Capex/Depreciation |
(0.15) | (0.21) | (0.16) | (0.13) | |
Revenue per Share |
1.77 | 1.41 | 1.09 | 0.51 | |
Operating CF per Share |
(0.85) | (0.44) | (1.01) | (1.63) | |
Capex per Share |
(0.03) | (0.03) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.03 |
Columns are period end dates